Advantech, CMBI lead $70m Series C round in China's InventisBio

Advantech, CMBI lead $70m Series C round in China's InventisBio

Photo: Bloomberg

Chinese clinical stage biotech company InventisBio Inc has raised a $70-million Series C financing round co-led by venture capital firm Advantech Capital and CMB International Capital Corporation Limited (CMBI), an investment unit of China Merchants Bank, according to an official release.

New investor Pudong Innotek and existing investors Lilly Asia Venture (LAV) and OrbiMed Asia also participated in the round.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter